Radiotherapy + CISPLATIN for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Mar 2026: Trial registered, NCT07497607
  2. 13 May 2026: Trial started, NCT07497607

The trials

NCT07497607: Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

State
Under way
Phase
Phase 2
People
31 planned
Started
13 May 2026
Primary completion
13 May 2031
Arms
Reduced Elective Nodal and CTV Dose
Results
None posted
  1. 27 Mar 2026: Trial registered
  2. 13 May 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.